Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 3
2018 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

4 results
Results by year
Filters applied: . Clear all
Page 1
Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series.
Kommoss S, McConechy MK, Kommoss F, Leung S, Bunz A, Magrill J, Britton H, Kommoss F, Grevenkamp F, Karnezis A, Yang W, Lum A, Krämer B, Taran F, Staebler A, Lax S, Brucker SY, Huntsman DG, Gilks CB, McAlpine JN, Talhouk A. Kommoss S, et al. Among authors: grevenkamp f. Ann Oncol. 2018 May 1;29(5):1180-1188. doi: 10.1093/annonc/mdy058. Ann Oncol. 2018. PMID: 29432521 Free article.
L1CAM: amending the "low-risk" category in endometrial carcinoma.
Kommoss F, Kommoss F, Grevenkamp F, Bunz AK, Taran FA, Fend F, Brucker SY, Wallwiener D, Schönfisch B, Greif K, Lax S, Staebler A, Kommoss S. Kommoss F, et al. Among authors: grevenkamp f. J Cancer Res Clin Oncol. 2017 Feb;143(2):255-262. doi: 10.1007/s00432-016-2276-3. Epub 2016 Sep 30. J Cancer Res Clin Oncol. 2017. PMID: 27695947
Disseminated tumor cells are not associated with established risk factors, L1CAM immunoreactivity and outcome in endometrial carcinoma.
Kommoss S, Hartkopf AD, Krämer B, Bunz AK, Grevenkamp F, Kommoss F, Pasternak J, Arbabi SM, Wallwiener M, Staebler A, Lax SF, Brucker SY, Taran FA. Kommoss S, et al. Among authors: grevenkamp f. J Cancer Res Clin Oncol. 2017 Nov;143(11):2183-2188. doi: 10.1007/s00432-017-2474-7. Epub 2017 Jul 14. J Cancer Res Clin Oncol. 2017. PMID: 28710714